← Back to Search

Engagement Strategies for Adolescent Violence Prevention

N/A

Recruiting

Led By Patrick Carter, MD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks.

Awards & highlights

Study Summary

This trial will test if adding engagement strategies helps healthcare providers to reach and sustain SafERteens program across multiple settings.

Who is the study for?

This trial is for healthcare providers like nurses and social workers at certain study sites who are involved in screening or delivering the SafERteens program. Providers starting work more than 9 months after implementation or those not expected to complete these tasks in their roles cannot participate.Check my eligibility

What is being tested?

The study aims to test if adding engagement strategies (like narrative persuasion, reciprocity, personalized feedback, commitment) can improve the reach of the SafERteens violence prevention program when implemented by healthcare providers across various settings.See study design

What are the potential side effects?

Since this trial focuses on implementing a behavioral intervention rather than a medical treatment, traditional side effects associated with medications are not applicable. However, there may be indirect effects on staff workload or stress.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from the start of implementation to 52 weeks or the end of provider's employment if before 52 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Preliminary Efficacy: monthly reach by providers

Preliminary Efficacy: weekly reach by providers

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Reciprocity (randomized weekly, 1 of 4 options)Experimental Treatment1 Intervention

The reciprocity engagement strategy (ES) will be operationalized as an unsolicited $5 gift card with the SafERteens Logo. Randomized weekly.

Group II: Personalized feedback (randomized monthly, 1 of 2 options)Experimental Treatment1 Intervention

The feedback ES will be operationalized as a visual graphic of their personal performance screening and/or delivering SafERteens in relation to the mean of the provider group and/or towards a pre-set standard (i.e., screening 75% of adolescents; delivery rate of 75% of eligible youth). Personalized feedback or none will be randomized on a monthly basis.

Group III: Narrative Persuasion (randomized weekly, 1 of 4 options)Experimental Treatment1 Intervention

Narrative persuasion will be youth or provider testimonial about violence in their community and/or how SafERteens helped their development and reduced violence. Randomized weekly.

Group IV: Commitment (randomized weekly, 1 of 4 options)Experimental Treatment1 Intervention

Commitment will be operationalized as a pledge committing to screening and/or delivering SafERteens (depending on role). Randomized weekly.

Group V: Engagement Strategy Control (randomized weekly, 1 of 4 options)Active Control1 Intervention

The control condition will involve no ES for the weekly Engagement Strategies. Randomized weekly.

Group VI: Personalized feedback control (randomized monthly, 1 of 2 options)Active Control1 Intervention

The control condition will involve no personalized feedback. Randomized monthly

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Personalized Feedback

2013

N/A

~900

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,377,898 Total Patients Enrolled

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,162 Total Patients Enrolled

Patrick Carter, MDPrincipal InvestigatorUniversity of Michigan

Media Library

Reciprocity (randomized weekly, 1 of 4 options) Clinical Trial Eligibility Overview. Trial Name: NCT05821205 — N/A

Adolescent Violence Research Study Groups: Reciprocity (randomized weekly, 1 of 4 options), Narrative Persuasion (randomized weekly, 1 of 4 options), Commitment (randomized weekly, 1 of 4 options), Engagement Strategy Control (randomized weekly, 1 of 4 options), Personalized feedback control (randomized monthly, 1 of 2 options), Personalized feedback (randomized monthly, 1 of 2 options)

Adolescent Violence Clinical Trial 2023: Reciprocity (randomized weekly, 1 of 4 options) Highlights & Side Effects. Trial Name: NCT05821205 — N/A

Reciprocity (randomized weekly, 1 of 4 options) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05821205 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many health care centers are currently conducting this research project?

"The current study is accessible from 7 sites located in Fruitport, Grand Rapids and Muskegon among several other places. To limit the burden of travel, participants are encouraged to pick the closest site for their enrollment."

Answered by AI

Are there currently any enrollees for this experiment?

"Indeed, the information hosted on clinicaltrials.gov indicates that this experiment is enrolling patients. It was initially posted to the website on February 28th 2023 and has since been updated as of April 19th 2023. A total of 100 participants are needed from 7 distinct medical centres."

Answered by AI

How many participants are officially joining the research project?

"Affirmative. The clinical trial is currently recruiting participants, as reflected on its profile page hosted by clinicaltrials.gov which was originally created in February 28th 2023 and last updated April 19th of the same year. 100 patients must be recruited from 7 different medical centres for this study to reach completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation

Patrick Carter 2023. "Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05821205.